Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.
about
Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI)Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists.Identification of Optically Active Pyrimidine Derivatives as Selective 5-HT2C Modulators.
P2860
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@ast
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@en
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@nl
type
label
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@ast
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@en
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@nl
prefLabel
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@ast
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@en
Pyrimido[4,5-d]azepines as pot ...... ment for urinary incontinence.
@nl
P2093
P1476
Pyrimido[4,5-d]azepines as pot ...... tment for urinary incontinence
@en
P2093
Alan D Brown
Alan S Jessiman
Alison Bridgeland
Carly L Nichols
Colleen P Gibbons
Dominique Westbrook
Gavin A Whitlock
Giles Hanton
Gordon McMurray
James A Root
P304
P356
10.1016/J.BMCL.2010.11.120
P407
P577
2010-12-04T00:00:00Z